- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Hansa Biopharma AB
Industry Sector: HealthTechnology
CEO: Søren Tulstrup, MBA
Number Of Employees: 135
Enterprise Value: $285,498,079
PE Ratio: -1.81
Exchange/Ticker 1: SSE:HNSA
Exchange/Ticker 2: N/A
Latest Market Cap: $166,491,835
BioCentury | Nov 15, 2024
Product Development
BeiGene’s globalization story comes of age
New name, plans to domicile in Switzerland reflect maturation of oncology player
BioCentury | Sep 14, 2024
Management Tracks
Egle names Detheux chairman
Plus: BeiGene adds to commercial leadership, hiring Pfizer veteran Matt Shaulis, and updates from Wells Fargo, Flagship, Alume, Cytek, Aetion and 180 Life Sciences
BioCentury | Aug 24, 2024
Management Tracks
ReAlta names David Marek CEO, Paolo Martini to lead R&D
Plus: Matthew Shaulis to leave Hansa, and updates from Beacon and The Genome Partnership
BioCentury | Feb 24, 2024
Management Tracks
Petroutsas to lead U.S. commercial operations at Astellas
Plus: Evan Ballantyne named CFO at Hansa and updates from BostonGene and InflaRx
BioCentury | Sep 1, 2023
Management Tracks
Huguet to succeed Mayer at Ipsen
Plus: Junshi COO Hui departing, Kaufmann named CSO at Hansa
BioCentury | Mar 3, 2023
Management Tracks
Delaney leaving Aadi as CEO
Plus: new CEO of Personalis, and Shaulis made commercial head and president of Hansa’s U.S. affiliate
BioCentury | Jan 31, 2023
Management Tracks
Baxter’s Accogli named CEO of Chiesi
Plus: J&J CMO Waldstreicher retiring, and updates from the Broad Institute, Ring, Hansa, Vaccitech and Beyond Air
BioCentury | Jun 1, 2022
Management Tracks
Zentalis co-founder Gallagher now president
Plus DTx hires Huang as CMO and updates from neoX, Altoid and more
BioCentury | Jul 3, 2020
Deals
July 2 Quick Takes: Novartis to ante up $678M in settlement; plus Zai, Neoleukin, Base Genomics, Sarepta-Hansa, Dr. Reddy-Fujifilm
Items per page:
1 - 10 of 21